I told you so!
I worked with a company in early 2000 with similar approach. We didn't know better and now, looking back, I realize how obvious it was: destroying solid tumors will not cure cancer or prolong the life of the patients. This is why THLD is using combination therapy to mask the failure of this approach. WAKE UP guys, read a little!
I will post next week on ASCO and then from ASCO with my picks!
An interesting company, STML, who has the SGEN #$%$ their board, would seem to disagree with you. :-)
"Researchers have identified Cancer Stem Cells (CSCs) as the highly malignant "seeds" of tumors, typically comprising 1-5% of the tumor, that give rise to the majority (95-99%) of other tumor cells known as the "tumor bulk".
While standard therapies, including chemotherapy and radiation, may initially shrink tumors by killing tumor bulk, the failure of these therapies to eradicate CSCs may be a major contributor to treatment failure, tumor relapse and poor survival.
Accordingly, we believe that new therapies designed to target CSCs, in addition to tumor bulk, may represent a major advance in the fight against cancer. This premise has formed the basis of our drug development strategy, as illustrated."